Risant Health adds Integris Health as it deepens its nonprofit hospital strategy
Risant Health has agreed to acquire Integris Health, Oklahoma’s largest nonprofit health system, pending regulatory approval. The deal extends a strategy Kaiser Permanente set in motion two years ago: build a network of nonprofit systems that can absorb capital, technology, and operating expertise while shifting more care into value-based models.
Integris will keep its name, medical staff, and leadership after the transaction closes. Financial terms and the closing timeline were not disclosed. Even without those details, the direction of travel is unmistakable. Risant is pursuing scale, and Integris is looking for structural support at a moment when rising expenses and reimbursement pressure are squeezing margins across the sector.
Capital relief meets a strained balance sheet in Oklahoma
Integris enters the deal from a fragile financial position. The system has operated at a loss over the last two years, and net income in fiscal 2025 fell to $12 million from almost $27 million the year before, despite higher investment gains. In April, Integris said it expected more than $130 million in revenue losses in 2026 because of Medicare and Medicaid funding cuts tied to the GOP’s “Big Beautiful Bill,” along with anticipated service line and staff reductions.
S&P Global Ratings downgraded Integris last summer, pointing to a worsened balance sheet and declining cash on hand. Those pressures make the appeal of Risant’s model easy to understand. In a hospital environment where labor costs, supply costs, and government payment uncertainty can erode operating stability quickly, access to a larger parent organization can become a survival tool rather than a luxury.
One sentence captures the gravity of the moment: Integris cannot absorb this level of financial pressure alone.
Why Risant sees value in a larger nonprofit footprint
California nonprofit giant Kaiser launched Risant in 2024 with a stated goal of expanding access to value-based care while stabilizing the finances of smaller nonprofit systems. The company has already acquired Pennsylvania-based Geisinger in 2024 and North Carolina-based Cone Health in 2025, making Integris its third acquisition since launch.
Risant’s argument is straightforward. Larger systems can spread the cost of analytics, digital infrastructure, care management programs, and population-health tooling across more hospitals and physician groups. Those capabilities matter because value-based care depends on coordination, early intervention, and a tighter grip on avoidable utilization. In practical terms, technology can help identify high-risk patients sooner, direct them to the right setting, and reduce the leakage that undermines both clinical outcomes and financial performance.
Greg Adams, chair and CEO of Kaiser Permanente, described the broader ambition in the release as a move away from siloed, episodic care toward a value-based care approach centered on evidence-based care and healthier outcomes. The phrasing fits the business logic behind Risant’s growth: hospitals under one operating umbrella may be able to standardize workflows, negotiate more effectively, and invest in systems that smaller networks would struggle to build on their own.
Integris brings scale, but also the risk inherent in a large hospital network
Integris is not a small regional outpost. The system runs 20 acute and specialty hospitals and the largest physician network in Oklahoma, which gives Risant a substantial platform in a state with a wide footprint of inpatient and outpatient needs. That scale creates opportunity, but it also creates complexity. Integrating a large medical staff, multiple hospital settings, and a broad physician network requires more than branding continuity; it requires aligned incentives, shared data systems, and a governance structure that can move quickly without disrupting local operations.
Timothy Pehrson, Integris CEO, said in the release that the organization would gain access to investments and capabilities it could not build on its own at the same scale or speed. His comment points to the central bargain in this deal. Integris may trade some autonomy for the financial and technical backing needed to modernize operations and shore up resilience.
The challenge for any acquiring system is making that promise real at the bedside. Capital alone does not shorten waits, improve referrals, or stabilize staffing patterns unless it is translated into workflow redesign and care delivery changes that physicians, nurses, and administrators can sustain.
Early signs from Geisinger and Cone Health shape expectations
Risant says its earlier acquisitions have already produced operational gains. Geisinger and Cone Health have seen improved wait times and better access to care, and Geisinger has recorded a 1% operating margin improvement since joining Risant, according to the release.
Those examples will likely frame expectations for Integris, especially as hospital leaders and regulators watch whether the model can do more than preserve margins. Shorter waits and better access are attractive metrics because they are visible to patients and economically relevant to systems trying to reduce bottlenecks. Better throughput can ease emergency department crowding, open specialty appointments sooner, and reduce delays that cascade through the rest of the network.
Still, the unanswered issue sits in the implementation itself: whether the operating playbook that fits Geisinger or Cone can translate cleanly to Oklahoma’s market, payer mix, and workforce pressures. The structures may be similar, but every local health system carries its own clinical habits, contract obligations, and community expectations. A parent organization can provide the toolkit; it cannot guarantee the same result in every setting.
A growing nonprofit consolidation story now reaches Oklahoma
The transaction places Integris inside a broader consolidation trend among nonprofit systems that are searching for scale without becoming for-profit entities. Risant’s growth reflects a belief that health systems can protect nonprofit missions while using a larger corporate structure to manage cost, invest in technology, and push more care into value-based arrangements.
For patients and clinicians in Oklahoma, the near-term question is how quickly those promised benefits can be felt in day-to-day care. Access to capital can support new platforms and staffing models, but the return depends on execution across hospitals, clinics, and physician practices. Regulatory approval remains ahead, and the deal’s financial details have not been disclosed, leaving open how the acquisition will be financed and how quickly the integration work will begin.